Working Group to Study Pharmacist Compensation

Public Act 25-167 Not later than July 1, 2025, the chairpersons of the joint standing committee of the General Assembly having cognizance of matters relating to insurance, or their designees, shall convene a working group to study and make recommendations for legislation related to the compensation of pharmacists licensed under chapter 400j of the general statutes, who provide certain health care services, including, but not limited to, vaccine administration, HIV related tests, influenza-related tests and the prescribing of contraceptive devices or products approved by the federal Food and Drug Administration. For the purposes of this section, (1) "chain pharmacy" means any community pharmacy that is publicly traded or has not less than six stores located in this state, (2) "HIV-related test" and "influenza related test" have the same meanings as provided in section 20-633f of the general statutes, (3) "independent pharmacy" means any privately owned pharmacy that has not more than five stores located in this state, (4) "pharmacist" has the same meaning as provided in section 20-571 of the general statutes, and (5) "pharmacy benefits manager" has the same meaning as provided in section 38a-479aaa of the general statutes.